CordenPharma Caponago Announces Successful Approval of New Sterile Injectable Facility

Jun 28, 2016
CordenPharma is pleased to announce the completion and approval of its aseptic filling line in CordenPharma Caponago (IT) by the Italian AIFA for clinical and commercial supply. This addition to the existing terminal sterilization capabilities of the manufacturing facility will support customer development and commercial programs by providing expert service in aseptic filling of liquid and lyophilized vials and pre-filled syringes. The project was initiated in 2014, when CordenPharma had experienced an increasing demand from its customers in this market segment – in particular as it relates to the fully integrated supply of injectables together with peptide APIs.
 
Ernesto Petroselli, President of CordenPharma International comments, “This new investment in the aseptic development capacities of CordenPharma Caponago strengthens our Injectable Platform and positions us as a fully integrated CDMO. Furthermore, it is a testament to our overall commitment in responding to customers’ needs.”
 
The expansion, which complements the already existing sterile capability at the site and in CordenPharma Latina (IT), is an additional step in the ongoing capacity expansion process that CordenPharma continues to pursue. Their aim is to supply complete injectable manufacturing services spanning development to commercial scale, including integrated peptide and oligonucleotide manufacturing capabilities. 

Read the Full Press Release Here.